|
1
|
Wang N, Chen Y, Han Y, et al: Proteomic
analysis shows down-regulations of cytoplasmic carbonic anhydrases,
CAI and CAII, are early events of colorectal carcinogenesis but are
not correlated with lymph node metastasis. Tumori. 98:783–791.
2012.PubMed/NCBI
|
|
2
|
Chen G, Wang H, Miller CT, et al: Reduced
selenium-binding protein 1 expression is associated with poor
outcome in lung adenocarcinomas. J Pathol. 202:321–329. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang KC, Park DC, Ng SK, et al: Selenium
binding protein 1 in ovarian cancer. Int J Cancer. 118:2433–2440.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim H, Kang HJ, You KT, et al: Suppression
of human selenium-binding protein 1 is a late event in colorectal
carcinogenesis and is associated with poor survival. Proteomics.
6:3466–3476. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li T, Yang W, Li M, et al: Expression of
selenium-binding protein 1 characterizes intestinal cell maturation
and predicts survival for patients with colorectal cancer. Mol Nutr
Food Res. 52:1289–1299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Silvers AL, Lin L, Bass AJ, et al:
Decreased selenium-binding protein 1 in esophageal adenocarcinoma
results from posttranscriptional and epigenetic regulation and
affects chemosensitivity. Clin Cancer Res. 16:2009–2021. 2010.
View Article : Google Scholar
|
|
7
|
Zhang J, Dong WG and Lin J: Reduced
selenium-binding protein 1 is associated with poor survival rate in
gastric carcinoma. Med Oncol. 28:481–487. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Di Stasio M, Volpe MG, Colonna G, et al: A
possible predictive marker of progression for hepatocellular
carcinoma. Oncol Lett. 2:1247–1251. 2011.PubMed/NCBI
|
|
9
|
Khare S and Verma M: Epigenetics of colon
cancer. Methods Mol Biol. 863:177–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bae JM, Kim JH and Kang GH: Epigenetic
alterations in colorectal cancer: the CpG island methylator
phenotype. Histol Histopathol. 28:585–595. 2013.PubMed/NCBI
|
|
11
|
Dai Z and Jin Y: Promoter methylation of
the DLC1 gene and its inhibitory effect on human colon cancer.
Oncol Rep. 30:1511–1517. 2013.PubMed/NCBI
|
|
12
|
Enroth S, Rada-Iglesisas A, Andersson R,
et al: Cancer associated epigenetic transitions identified by
genome-wide histone methylation binding profiles in human
colorectal cancer samples and paired normal mucosa. BMC Cancer.
11:4502011. View Article : Google Scholar
|
|
13
|
Zhang S, Li F, Younes M, Liu H, Chen C and
Yao Q: Reduced selenium-binding protein 1 in breast cancer
correlates with poor survival and resistance to the
anti-proliferative effects of selenium. PLoS One. 8:e637022013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Linge A, Kennedy S, O’Flynn D, et al:
Differential expression of fourteen proteins between uveal melanoma
from patients who subsequently developed distant metastases versus
those who did not. Invest Ophthalmol Vis Sci. 53:4634–4643. 2012.
View Article : Google Scholar
|
|
15
|
Giusti L, Iacconi P, Da Valle Y, et al: A
proteomic profile of washing fluid from the colorectal tract to
search for potential biomarkers of colon cancer. Mol Biosyst.
8:1088–1099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Luo HS and Xia H: Sodium butyrate
induces human colon carcinoma HT-29 cell apoptosis through a
mitochondrial pathway. J Int Med Res. 37:803–811. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Orchel A, Dzierzewicz Z, Parfiniewicz B,
Weglarz L and Wilczok T: Butyrate-induced differentiation of colon
cancer cells is PKC and JNK dependent. Dig Dis Sci. 50:490–498.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruan W, Zhu S, Wang H, et al: IGFBP-rP1, a
potential molecule associated with colon cancer differentiation.
Mol Cancer. 9:2812010.PubMed/NCBI
|
|
19
|
Li Q and Chen H: Silencing of Wnt5a during
colon cancer metastasis involves histone modifications.
Epigenetics. 7:551–558. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Jackson LN, Johnson SM, Wang Q and
Evers BM: Suppression of neurotensin receptor type 1 expression and
function by histone deacetylase inhibitors in human colorectal
cancers. Mol Cancer Ther. 9:2389–2398. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krishnan M, Singh AB, Smith JJ, et al:
HDAC inhibitors regulate claudin-1 expression in colon cancer cells
through modulation of mRNA stability. Oncogene. 29:305–312. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pohl NM, Tong C, Fang W, Bi X, Li T and
Yang W: Transcriptional regulation and biological functions of
selenium-binding protein 1 in colorectal cancer in vitro and in
nude mouse xenografts. PLoS One. 4:e77742009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pierce GB and Johnson LD: Differentiation
and cancer. In Vitro. 7:140–145. 1971. View Article : Google Scholar
|
|
24
|
Meng CF, Zhu XJ, Peng G and Dai DQ: Role
of histone modifications and DNA methylation in the regulation of
O6-methylguanine-DNA methyltransferase gene
expression in human stomach cancer cells. Cancer Invest.
28:331–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brait M, Ling S, Nagpal JK, et al:
Cysteine dioxygenase 1 is a tumor suppressor gene silenced by
promoter methylation in multiple human cancers. PLoS One.
7:e449512012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roy S, Levi E, Majumdar AP and Sarkar FH:
Expression of miR-34 is lost in colon cancer which can be
re-expressed by a novel agent CDF. J Hematol Oncol. 5:582012.
View Article : Google Scholar : PubMed/NCBI
|
